EUVIMEDEUVIMED entdecken
Systematische ÜbersichtVergleichsstudieNetzwerk-Metaanalyse

Intravenous Versus Subcutaneous Tranexamic Acid in Liposuction: A Comparative Analysis of Efficacy and Safety

Mustafa Qais Al-Khafaji, Aashna Mehta, Ibrahim R Halawani, Joel Edassery Vivek, Kenneth Joshua George, Syed Hasham Ali, Shahad Qais Al-Khafaji, Édua Pluzsnyik, Yousif Qais Al-Khafaji, Murtadha Qais Al-Khafaji, Raja Adil Ali, Abdulaziz Alabdulkarim iD

Aesthetic Plastic Surgery · 2025

DOI: 10.1007/s00266-025-05173-4 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Mustafa Qais Al-Khafaji und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Norfolk and Norwich University Hospital, Norwich, UK. Hauptthemen laut MEDLINE: Tranexamic Acid, Lipectomy, Antifibrinolytic Agents, Blood Loss, Surgical. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liposuction is among the most carried-out aesthetic procedures in the world and is usually associated with considerable intraoperative blood loss. Tranexamic acid is an antifibrinolytic agent commonly used to minimize blood loss during surgery. However, there is scant evidence regarding the comparative efficacy and safety of intravenous administration versus subcutaneous administration during liposuction. METHODS: PRISMA guidelines were followed for this systematic review and meta-analysis. A total of 10 studies that investigated TXA in liposuction published from 2000 to 2024 were identified from the overall search across PubMed, Google Scholar, and Ovid. Main outcomes evaluated the changes in hematologic parameters (hemoglobin and hematocrit), perioperative blood loss, and postoperative complications. Random-effects models and network meta-analyses comparing IV and SC routes of administration were conducted. RESULTS: TXA significantly reduced intraoperative blood loss and improved postoperative hematologic stability. IV TXA proved to be more effective with a decrease in hematocrit change than SC (MD - 2.43, 95% CI [- 3.84, - 1.03]) and placebo (MD - 3.06, 95% CI [- 4.36, - 1.76]), while SC TXA showed a significant improvement in postoperative hemoglobin levels (MD 0.54, 95% CI [0.07, 1.01]). Both routes were associated with low complication rates, and no thromboembolic event was noted in either group. CONCLUSION: TXA is effective in reducing blood loss during liposuction, with IV administration showing greater hematologic stabilization. SC administration remains a safe and viable alternative. Further high-quality trials are needed to refine dosing strategies and explore long-term outcomes. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidLipectomyAntifibrinolytic AgentsBlood Loss, SurgicalHumansInjections, SubcutaneousTreatment OutcomeAdministration, IntravenousFemale

Stichwörter der Autor:innen

Blood lossIntravenous TXALiposuctionSubcutaneous TXATranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Department of Plastic Surgery, Norfolk and Norwich University Hospital, Norwich, UK.
  • Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • , Gothenburg, Sweden.
  • Department of Trauma and Orthopaedics, Frimley Park Hospital, Frimley, UK.

ORCID-Profile: Abdulaziz Alabdulkarim

Zitieren

APA

Al-Khafaji, M. Q., Mehta, A., Halawani, I. R., Vivek, J. E., George, K. J., Ali, S. H., Al-Khafaji, S. Q., Pluzsnyik, É., Al-Khafaji, Y. Q., Al-Khafaji, M. Q., Ali, R. A., & Alabdulkarim, A. (2025). Intravenous Versus Subcutaneous Tranexamic Acid in Liposuction: A Comparative Analysis of Efficacy and Safety. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05173-4

Vancouver

Al-Khafaji MQ, Mehta A, Halawani IR, Vivek JE, George KJ, Ali SH, et al. Intravenous Versus Subcutaneous Tranexamic Acid in Liposuction: A Comparative Analysis of Efficacy and Safety. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-05173-4

BibTeX
@article{AlKhafaji2025,
  author = {Al-Khafaji, Mustafa Qais and Mehta, Aashna and Halawani, Ibrahim R and Vivek, Joel Edassery and George, Kenneth Joshua and Ali, Syed Hasham and Al-Khafaji, Shahad Qais and Pluzsnyik, Édua and Al-Khafaji, Yousif Qais and Al-Khafaji, Murtadha Qais and Ali, Raja Adil and Alabdulkarim, Abdulaziz},
  title = {Intravenous Versus Subcutaneous Tranexamic Acid in Liposuction: A Comparative Analysis of Efficacy and Safety},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  doi = {10.1007/s00266-025-05173-4}
}
Kostenlos starten →